...
首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Quantitative structure-activity relationship studies of diarylpyrimidine derivatives as anti-HIV drugs using new three-dimensional structure descriptors
【24h】

Quantitative structure-activity relationship studies of diarylpyrimidine derivatives as anti-HIV drugs using new three-dimensional structure descriptors

机译:使用新的三维结构描述符对二芳基嘧啶衍生物作为抗HIV药物进行定量构效关系研究

获取原文
获取原文并翻译 | 示例

摘要

A novel three-dimensional holographic vector of atomic interaction field (3D-HoVAIF) was used to describe the chemical structures of 34 wild-type DAPYs, 33 mutant form L100I, 30 mutant form Y181C and 29 mutant form Y188L as anti-HIV drugs. Here four quantitative structure activity relationship models were built by partial least square regression. The estimation stability and prediction ability of models were strictly analyzed by both internal and external validations. The correlation coefficient (R_(cum)~2, leave-one-out cross-validation correlation coefficient (Q_(CV)~2) and predicted values versus experimental ones of external samples (Q_(ext)~2) were 0.925, 0.769 and 0.949 for 34 diarylpyrimidines; 0.899, 0.788 and 0.889 for 33 mutant form L100I; 0.844, 0.761 and 0.935 for 30 mutant form Y181C; 0.890, 0.757 and 0.912 for 29 mutant form Y188L. These values indicated that the built PLS models had both favorable estimation stability and good prediction capabilities. Furthermore, the satisfactory results showed that 3D-HoVAIF could preferably express the information related to the biological activity of DAPY derivatives.
机译:用新型的三维原子相互作用场全息载体(3D-HoVAIF)描述了34种野生型DAPYs,33种L100I突变体,30种Y181C突变体和29种Y188L突变体的化学结构。在这里,通过偏最小二乘回归建立了四个定量结构活性关系模型。内部和外部验证都严格分析了模型的估计稳定性和预测能力。相关系数(R_(cum)〜2,留一法交叉验证相关系数(Q_(CV)〜2)和预测值与外部样本的实验值(Q_(ext)〜2)分别为0.925、0.769 34个二芳基嘧啶为0.949; 33个L100I突变体形式为0.899、0.788和0.889; 30个Y181C突变体形式为0.844、0.761和0.935; 29个Y188L突变体形式为0.890、0.757和0.912。估计的稳定性和良好的预测能力,此外,令人满意的结果表明3D-HoVAIF可以较好地表达与DAPY衍生物的生物活性有关的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号